About DarioHealth
DarioHealth is a publicly traded digital health company that delivers comprehensive solutions for chronic disease management across multiple conditions. The company's integrated platform addresses cardiometabolic health (diabetes, prediabetes, hypertension, weight management), musculoskeletal conditions (chronic pain, posture, injury prevention), and behavioral health (anxiety, depression, stress). DarioHealth's approach combines consumer-centric technology with clinical evidence, offering connected medical devices, a highly-rated mobile app (4.9/5 stars), and personalized support from certified health coaches. The platform serves an average of 2.4 chronic conditions per member and maintains an 80% retention rate. Members receive real-time support through live coaching, expert-level care access, and self-guided programs incorporating multiple evidence-based clinical modalities. The company's solutions integrate with devices like Dexcom CGM and Apple Health, and include innovative features such as medication management, grocery scanning, and biofeedback-enabled exercise therapy. DarioHealth serves employers, health plans, consultants, and pharmaceutical companies, delivering demonstrated ROI of 3.4-6X for partners. Clinical outcomes include 1.4% reduction in A1c for diabetes, 38% reduction in blood pressure by one stage, 54% reduction in severe pain for MSK conditions, and 26% reduction in depression and anxiety symptoms. The company also offers specialized GLP-1 medication support solutions.
Clinical Focus
Medical conditions and clinical areas addressed by DarioHealth.
Who It Serves
Milestones & Awards
Recent Milestones
GLP-1 solution launch combining behavior change with anti-obesity medication support; Dexcom CGM integration; Apple Health integration; Grocery scanner feature; Medication cabinet feature
Awards & Recognition
4.9/5 star rating in App Store, 77 NPS Score
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.